Get started
BADQOMOCAWGOWLD

$ENSC entry PT 1.25-1.50 Target PTs 6-7 and higher

Long
Ensysce Biosciences, Inc. (NASDAQ:ENSC)  
BADQOMOCAWGOWLD  
NASDAQ:ENSC   Ensysce Biosciences, Inc.
Beyond Technical Analysis Fundamental Analysis Chart Patterns strength Supply Zone target rangezone buy buysignal buysetup waitforbreakout
3
0
beyondta fundamental chartpattern strength supplyzone target rangezone buy buysignal buysetup waitforbreakout
Ensysce Biosciences shares are trading higher after Zacks Small-Cap Research set a $23 valuation on the stock.

Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs. The company is developing tamper-proof opioids using Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms. Its products treat severe pain and assist in preventing deaths caused by opioid abuse. The company is headquartered in La Jolla, California.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.